Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project
|Study Design:||Observational Model: Case-Only
Time Perspective: Cross-Sectional
|Official Title:||Gynecological Cancer Survivors` Views on Follow-up After Cancer Treatment|
- Patient expectation questionnaire [ Time Frame: within the first 30 days after primary treatment ] [ Designated as safety issue: No ]The patients will be asked to fill in a quesionnaire regarding their expectations on follow-up care
- Patient satisfaction questionnaire [ Time Frame: 3 years after treatment ] [ Designated as safety issue: No ]The patients will be asked to fill in a quesionnaire regarding their satisfaction on follow-up care after three years
|Study Start Date:||September 2012|
|Study Completion Date:||December 2015|
|Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|
|recently treated patients|
|2-3 years after treatment|
After gynaecological cancer patients have completed their treatment, they are followed up at a gynaecological outpatient clinic for a number of years. The aim of such follow-up is to detect recurrence, improve survival and reduce adverse effects of the treatment. The national guide for oncological gynaecology recommends follow-up by a specialist for five years at intervals depending on cancer type. Several review studies on follow-up of endometrial, cervical and ovarian cancer patients show large international variations in follow-up routines. There are only retrospective studies available, and they indicate that most recurrences are discovered within the first three years after completed treatment, and, in most cases, by the women themselves. More intensive surveillance does not appear to affect the time for discovery of recurrence.
A few randomised controlled studies and retrospective cohort studies have been published that focus on follow-up of colon cancer and breast cancer patients by general practitioners versus by hospital specialists. These studies have not shown any significant differences between the groups in terms of detection of recurrence, incidence of serious clinical events connected with recurrence or health-related quality of life.
The investigators therefore plan to perform a study in which both gynaecological cancer patients and their regular general practitioners are asked about their views on patient follow-up after completed treatment. The investigators especially wish to focus on the collaboration aspect.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01691144
|Sorlandet Hospital Kristiansand|
|Kristiansand, Norway, 4621|
|St. Olavs Hospital|
|Trondheim, Norway, 7030|
|Study Chair:||Mette Brekke, PhD||University of Oslo|